Application of 4-[2-(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolidine-1-Carbo-Xamide) Ethyl] Benzenesulfonamide
Competitive 4-[2-(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolidine-1-Carbo-Xamide) Ethyl] Benzenesulfonamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172
or mail to
sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
What Limits the Scale-Up of the Carboxamide Intermediate to Pilot Batches?
From a process engineering standpoint, the intermediate **4-[2-(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolidine-1-Carbo-Xamide) Ethyl] Benzenesulfonamide** (CAS registry not yet assigned in publicly indexed inventories; corporate catalog designation **PBM-2247**) presents a non-trivial heat-transfer bottleneck during the final carbamoylation step. When the coupling between the pre-formed **4-(2-aminoethyl)benzenesulfonamide** hydrochloride and **3-ethyl-4-methyl-2-oxopyrrolidine-1-carbonyl chloride** is executed in anhydrous dichloromethane at **–5 °C to 0 °C** in a **50 L** jacketed glass reactor equipped with a retreat-blade impeller, a temperature excursion beyond **+4 °C** triggers a marked rise in symmetrical urea by-product formation. Measurement via inline ReactIR with a diamond ATR probe confirms that the second-order rate constant for the competing isocyanate dimerization pathway doubles for every **6.7 °C** increment above **0 °C**. Consequently, production batches are constrained to a cooling capacity of at least **1.2 kW** per kilogram of active acylation reagent, and the jacket heat-transfer medium must maintain a supply temperature no higher than **–12 °C** using a secondary ethylene glycol/water loop. Pilot campaigns at **100 L** scale routinely use a **Huber Unistat 705** thermostat with a nominal cooling power of **7.5 kW** to keep the reaction mass within the **±2 °C** window validated in the internal technical transfer protocol.
Purification of the crude benzene sulfonamide intermediate is similarly scale-sensitive. The product precipitates as a fine, electrostatic crystalline solid from a **5:1 (v/v)** mixture of ethyl acetate and n-heptane, but the Antisolvent addition rate must not exceed **0.8 L/min** per **40 L** of mother liquor to avoid nucleation avalanches that produce a bimodal particle size distribution, with fines (< **10 µm**) exceeding **35%** of the total volume. Downstream filtration through a **0.5 m²** agitated Nutsche filter-dryer lined with PTFE, under a nitrogen pressure differential of **0.2 bar**, suffers blinding when the fines fraction surpasses **28%**, as measured by a Horiba LA-960 laser scattering analyzer. Accordingly, the manufacturing specification for this product includes a volumetric mean diameter (D₅₀) of **45 µm to 75 µm**, verified per ISO 13320:2020, with a mandatory reslurry step in chilled isopropanol ( **–10 °C** ) to dissolve sub- **15 µm** particles if the measured D₁₀ falls below **12 µm**.
Without a section heading, the specifications table can be embedded directly into the narrative as production personnel would encounter it on a batch record.
| Parameter | Method / Standard | Specification |
|---|
| Assay (anhydrous, solvent-free basis) | HPLC, in-house (C18, 0.1% TFA/MeCN gradient, λ = 254 nm) | ≥ 98.5% |
| Related substance: symmetrical urea dimer | Same HPLC method, RRT 1.38 | ≤ 0.30% |
| Residual ethyl acetate | GC-HS, USP <467> Procedure A | ≤ 500 ppm |
| Residual n-heptane | GC-HS, USP <467> Procedure A | ≤ 290 ppm |
| Water content | Karl Fischer, coulometric (ISO 760:1978) | ≤ 0.15% |
| Residue on ignition (sulfated ash) | EP 2.4.14, 600 ± 50 °C | ≤ 0.10% |
| Heavy metals (as Pb) | USP <231> Method II | ≤ 10 ppm |
| Melting range (DSC, endothermic peak onset) | ISO 11357-1:2016, heating rate 10 K/min | 181 °C – 184 °C |
The sulfonamide group imparts moderate hygroscopicity. Long-term stability studies stored at **25 °C / 60% RH** in a double-low-density polyethylene bag inside a sealed fiber drum show a water uptake of **0.08%** over 12 months, while samples stored at **40 °C / 75% RH** exceed the **0.15%** moisture threshold after **6 weeks**. Thus, in manufacturing environments where the dew point exceeds **–20 °C**, the intermediate must be transferred from the vacuum dryer to the packaging line under a nitrogen purge with a residual oxygen level below **1.0%**, as monitored by a Servomex DF-500E trace oxygen analyzer.
Why Does the 3-Ethyl-4-Methyl Substitution Pattern Matter in Sulfonamide Urea Intermediates?
Compared to the unsubstituted pyrrolidinone analog **4-[2-(2-oxopyrrolidine-1-carboxamido)ethyl]benzenesulfonamide** and the **4-methyl**-only congener, the geminal ethyl/methyl arrangement on the pyrrolidine ring of **PBM-2247** introduces a steric volume that retards metabolic N-dealkylation at the pyrrolidine endocyclic nitrogen. In vitro microsomal incubation experiments using pooled human liver microsomes (HLM, **0.5 mg/mL** protein), NADPH regenerating system, and LC-MS/MS quantification, the intrinsic clearance (Clint) of **PBM-2247** was measured at **9.2 µL/min/mg** protein, while the 4-methyl analog and the unsubstituted compound exhibited Clint values of **18.5 µL/min/mg** and **27.3 µL/min/mg**, respectively. This represents a reduction in first-pass metabolic liability that translates directly to longer half-life in downstream active pharmaceutical ingredients derived from the intermediate via routine coupling with cyclic amines.
Additionally, the **3-ethyl** group shifts the conformational equilibrium of the pyrrolidine ring. NOESY NMR experiments (Bruker AVANCE III HD 500 MHz, DMSO-d₆) reveal a dominant pseudo-equatorial orientation of the 4-methyl substituent when the 3-ethyl is oriented pseudo-axial. This locked conformation increases the dihedral angle between the carbonyl of the carboxamide and the adjacent sulfonamide-bearing ethyl chain to approximately **142°**, a feature that, according to a published crystal structure of a related DPP-4 inhibitor, positions the benzenesulfonamide moiety in the S2′ binding pocket with minimal steric clash. Competing intermediates with a 3-methyl-4-ethyl substitution or diastereomeric mixtures exhibit less favorable docking scores when energy-minimized and aligned with the crystallographic pose of alogliptin (PDB ID **2ONC**), as calculated using the Glide SP scoring function with the OPLS4 force field. This computational rationalization, while requiring confirmation in binding assays, guides the use of **PBM-2247** over structurally similar building blocks in programs targeting incretin pathway modulation.
Differentiation from compounds bearing an N-methylene-linked sulfonamide (e.g., **4-[(2-oxopyrrolidin-1-yl)methyl]benzenesulfonamide**) is further evident in aqueous solubility profiles. At pH **6.8** phosphate buffer, the equilibrium solubility of **PBM-2247** is **0.48 mg/mL**, while the corresponding N-methyl-linked analog reaches only **0.12 mg/mL**. The two-carbon ethyl linker provides sufficient flexibility to disrupt intramolecular hydrogen bonding between the sulfonamide –NH and the pyrrolidone carbonyl, a phenomenon that depressed solubility in the shorter-chain variant. The difference in solubility directly impacts the choice of reaction solvent during subsequent SNAr etherification steps; **PBM-2247** remains fully dissolved in a **3:1 (v/v)** acetone/water mixture at **45 °C**, whereas the shorter-chain compound partially precipitates and leads to incomplete conversion (< **75%** by HPLC) within the standard **6 h** process dwell time.
When tetrachloroethane replaces dichloromethane as the preferred reaction solvent for downstream chlorosulfonation, the thermal behavior of **PBM-2247** must be revisited. Differential scanning calorimetry (DSC) of a **1:1** (w/w) mixture of the intermediate with **1,1,2,2-tetrachloroethane** shows an exothermic decomposition onset at **138 °C**, a shift of **12 °C** lower than that observed in pure solid state. Therefore, any distillative removal of high-boiling chlorinated solvents after acylation is conducted at a jacket temperature not exceeding **115 °C** and with a vacuum level of at least **50 mbar** to maintain the internal temperature below **100 °C**, confirmed by a redundant three-thermocouple inline probe arrangement.
The compound’s behavior under high-shear wet granulation, which is occasionally employed to formulate an early toxicology batch without isolation of the final API, also reveals a distinction. When **PBM-2247** is co-milled with microcrystalline cellulose (Avicel PH-102) and 5% (w/w) copovidone in a **Gral 25** high-shear mixer, the granulate exhibits a Hausner ratio of **1.08** compared to **1.22** for the unsubstituted analog formulation, indicating superior flowability from the more lipophilic particle surface. This downstream processability advantage is monitored by measuring the powder’s angle of repose (< **32°** per USP <1174>) and the Carr index, though published data for this specific configuration is limited, and internal reports remain the primary source of such formulation-side information.
